On Monday, Judge Alan D. Albright denied Apple Inc.’s motion to transfer venue in a case involving patented “slide to unlock” smart device interface...
Novartis announced plans to acquire Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company developing medicines targeting microRNAs, for $800...